Search company, investor...
FBSciences company logo


Founded Year



Acquired | Acquired

Total Raised


About FBSciences

FBSciences develops a plant healthcare technology designed to help in crop yield. The technology includes biostimulants, fertilizers, and pesticides based on its technologies for crop protection and crop nutrition. The company was founded in 2007 and is based in Collierville, Tennessee. In January 2023, FBSciences was acquired by Valent BioSciences. The terms of the transaction were not disclosed.

Headquarters Location

153 North Main Street Suite 100

Collierville, Tennessee, 38017,

United States


Missing: FBSciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: FBSciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing FBSciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

FBSciences is included in 1 Expert Collection, including Agriculture Technology (Agtech).


Agriculture Technology (Agtech)

1,931 items

Companies that are using technology to make farms more efficient.

FBSciences Patents

FBSciences has filed 12 patents.

The 3 most popular patent topics include:

  • Inorganic compounds
  • Metal halides
  • Nutrition
patents chart

Application Date

Grant Date


Related Topics




Inorganic compounds, Nutrition, Potassium compounds, Fatty acids, Nepenthes


Application Date


Grant Date



Related Topics

Inorganic compounds, Nutrition, Potassium compounds, Fatty acids, Nepenthes



Latest FBSciences News

Valent BioSciences To Acquire FBSciences

Jan 31, 2023

January 31, 2023 LIBERTYVILLE, Ill.–( BUSINESS WIRE )–Valent BioSciences, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces its acquisition of FBSciences Holdings, a leader in the discovery and commercialization of naturally derived plant, soil, and climate health solutions. With this acquisition, Valent BioSciences and its parent company, Sumitomo Chemical, now offer an innovative and proven portfolio of integrated biorational solutions, including biostimulants, biopesticides, and crop nutrition solutions. The acquisition of FBSciences, a recognized leader in biostimulants headquartered in Collierville, Tennessee, greatly strengthens Valent BioSciences’ participation in the rapidly growing $3.5 billion global biostimulant market. On October 1, 2022, Valent BioSciences began selling biostimulant products directly to its U.S. customer base. This acquisition will provide a significant growth platform for the two companies’ wide range of crop enhancement and crop protection products and forms a key pillar in the overall business strategy. FBSciences’ portfolio of biorational technologies is naturally derived, renewable, and sustainable, and forms the foundation of a wide offering of innovative solutions for agriculture. The company’s core technologies are derived from natural organic matter (NOM) utilizing proprietary production processes that target and extract a diverse mixture of unique and biologically active compounds that transform plant, soil, and climate health. With a science-based approach and decades of research, FBSciences delivers powerful technologies and products with a track record of superior performance and proven commercial success. The company’s flagship biostimulant technology, FBS Transit®, forms the foundation of its crop nutrition and nutrient use efficiency product lines for use on all crops. It works inside the plant to increase the uptake and translocation of all nutrients, leading to healthier plants that can withstand stress, which results in increased yields and quality. FBSciences’ biopesticide technology, FBS Defense™, works within the plant to increase its ability to defend itself from biotic stresses, including insects and diseases, and increases harvestable yields. Both companies are well recognized for their industry-leading research and development capabilities, which will spark rapid innovation and commercialization of new technologies and products to deliver substantial growth for the biorationals arena. “The acquisition of FBSciences is a natural next step in the evolution of our organization as a global leader in biorationals, including biostimulants,” said Ted Melnik, President and CEO of Valent BioSciences. “Our combined organizations have many decades of experience leading our respective markets with science-based technology and innovation. The wide range of biostimulant, biopesticide, and crop nutrition products and technologies in the FBSciences portfolio augments Valent BioSciences’ broad family of biorational products, thereby creating an unmatched range of value-added and sustainable solutions that no other company can provide.” Sumitomo Chemical has pledged to achieve carbon neutrality by 2050, aiming to reduce the amount of greenhouse gases emitted by its production and business activities. “Valent BioSciences’ keen focus on developing products that sequester atmospheric carbon, combined with FBSciences’ technologies, will help accelerate this effort,” said Nobuaki Mito, Director and Senior Managing Executive Officer of Sumitomo Chemical. “This acquisition will step forward our Green Transformation strategy initiatives and contribute to realizing sustainable agriculture and society in the future.” “The acquisition of FBSciences by Valent BioSciences is a major leap forward for the biorational industry,” said Courtenay Wolfe, CEO and Chairwoman of FBSciences. “This tremendous milestone for FBSciences recognizes 16 years of success developing and commercializing transformative plant, soil, and climate health solutions. Our companies share a common rooted-in-science approach coupled with a mission to better society and our planet. Adding FBSciences’ expertise, innovative solutions, and entrepreneurial spirit to Valent BioSciences’ global powerhouse of resources and robust solutions will deliver a platform unrivaled in the industry and continue to propel Valent BioSciences’ leadership position in the rapidly growing biorational space.” About Valent BioSciences LLC Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at . About FBSciences Holdings, Inc. FBSciences is a global leader in the innovation and commercialization of climate-smart biorationals for agriculture. The company’s naturally derived, proprietary technologies are the foundation for its biostimulant, biopesticide, and crop nutrition product lines. FBSciences has proven that its technologies and products increase quality and nutrient density, improve stress mitigation and recovery, produce healthier plants and higher yields, and increase utilization of other crop inputs. In addition, the company’s sustainable products provide measurable benefits to the environment, including increased nitrogen use efficiency, leading to N2O emissions reduction, decreased nitrogen runoff, and reduced CO2 emissions by increased carbon sequestration. With an opportunity for meaningful impact on every managed acre, FBSciences is committed to harnessing the power of nature to transform agriculture globally. For additional information, visit the company’s website at .

FBSciences Frequently Asked Questions (FAQ)

  • When was FBSciences founded?

    FBSciences was founded in 2007.

  • Where is FBSciences's headquarters?

    FBSciences's headquarters is located at 153 North Main Street, Collierville.

  • What is FBSciences's latest funding round?

    FBSciences's latest funding round is Acquired.

  • How much did FBSciences raise?

    FBSciences raised a total of $22.74M.

  • Who are the investors of FBSciences?

    Investors of FBSciences include Valent BioSciences and Paycheck Protection Program.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.